NeoStem, Inc. Robin L. Smith, M.D., MBA - Chairman and CEO Signature Series


Watch the CEO signature series interview with Robin L. Smith, M.D., MBA

Dr. Robin L. Smith's expertise in business development and medicine includes her extensive and diversified experience serving in executive and board level capacities for various medical enterprises and healthcare-based entities. Since 2006, Dr. Smith has served as Chairman and CEO of NeoStem, a rapidly growing company in the stem cell sector. In 2010, NeoStem earned the New Economy "Best Stem Cell Company" award. Dr. Smith has successfully led the business in completing five acquisitions and one divestiture as well as raised over 100 million dollars toward building one of the leading companies in the emerging cell therapy industry.

From 2000 to 2003, Dr. Smith served as President & Chief Executive Officer of IP2M, a multi-platform media company specializing in healthcare. During her term, the company was selected as being one of the 10 fastest growing technology companies in Houston, Texas. IP2M was sold to a publicly traded company in February 2003. Previously, from 1998 to 2000, Dr. Smith was Executive Vice President and Chief Medical Officer for HealthHelp, Inc., a national radiology management company that managed 14 percent of all healthcare dollars spent by large insurance companies.

Dr. Smith has acted as a senior advisor to, and investor in, both publicly traded and privately held companies where she has played a significant role in restructuring and or growing such businesses. She currently serves on the Board of Trustees of the NYU Langone Medical Center and is past Chairman of the Board of Directors for the New York University Hospital for Joint Diseases where she headed up new development efforts and board member recruitment. Dr. Smith has also served on the Board of Choose Living as well as other public and private companies. Currently, Dr. Smith is the President and serves as Chairman of the Board of Directors of The Stem for Life Foundation, a non-profit entity with the goal of educating the public about the growing benefits of stem cell therapies and applications.  She was also appointed to the Board of Directors, Science and Faith STOQ Foundation in Rome as well as the Capital Formation Committee of the Alliance for Regenerative Medicine.

Dr. Smith received her medical degree from Yale University where she was presented with the Janet M. Glasgow Memorial Achievement Citation awarded by the American Medical Women’s Association to those women who graduate first in their class from medical schools throughout the country.  She was also elected to Alpha Omega Alpha and chosen to be a Farr Scholar. She received her Master of Business Administration degree from the Wharton School of Business, where she made the Director’s List for being in the top 10% of her class.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

This article appears in: Investing , Basics

Referenced Stocks: NBS

Nasdaq CEO Signature Series

  • See all for Nasdaq CEO Signature Series
  • View Print Version

More from Nasdaq CEO Signature Series:

Related Videos




Most Active by Volume

  • $102.47 ▲ 2.72%
  • $16.60 ▲ 2.09%
  • $13.21 ▼ 5.64%
  • $40.685 ▼ 6.02%
  • $96.87 ▲ 2.63%
  • $9.26 ▲ 1.09%
  • $31.16 ▲ 4.95%
  • $28.28 ▲ 1.25%
As of 10/21/2014, 04:02 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by